Live Breaking News & Updates on Department Of Gynecology

Stay updated with breaking news from Department of gynecology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Modesitt on Shared Decision-Making When Choosing PARP Inhibitors in Ovarian Cancer

Susan C. Modesitt, MD, FACOG, FACS, discusses the role of PARP inhibitors in the treatment of patients with ovarian cancer. ....

Susanc Modesitt , Division Of Gynecologic Oncology , Emory University School Of Medicine , Department Of Gynecology , Gynecologic Oncology , Emory University School ,

Dr Meisel on Perceptions of Patient/Provider Communication in Breast Cancer Care

Jane L. Meisel, MD, shares information from a study that evaluated patient-reported perceptions of patient-provider communication in breast cancer care. ....

Janel Meisel , Emory University School Of Medicine , Department Of Hematology , Department Of Gynecology , Medical Oncology , Emory University School ,

Dr Meisel on Patient-Reported Perceptions of Provider Communication in Breast Cancer Care

Jane L. Meisel, MD, discusses patient-reported perceptions of patient-provider communication in cancer care. ....

Janel Meisel , Department Of Gynecology , Emory University School Of Medicine , Department Of Hematology , Medical Oncology , Emory University School , Winship Cancer Institute Of Emory University , Onclive Tv , Breast Cancer ,

Patient Toxicity and QOL Concerns Must Be Considered in Breast Cancer Treatment Decision-Making

Jane L. Meisel, MD, discusses the importance of prioritizing patients’ toxicity concerns and quality of life in the management of breast cancer. ....

United States , Emory University School Of Medicine , San Antonio , Janel Meisel , Department Of Gynecology , Quality Of Life , Department Of Hematology , Life Survey , Antonio Breast Cancer Symposium , Medical Oncology , Emory University School , Estrogen Receptor Positive Her2 Negative , Breast Cancer , Treatment Related Adverse Effects , Healthcare Providers , Tolerability Concerns , Shared Decision Making , Esr1 Quality Of Life Survey 3 , Quality Of Life , 2023 San Antonio Breast Cancer Symposium ,

Addressing Patient-Provider Communication Challenges is Vital for Improved Breast Cancer Care

Jane L. Meisel, MD, highlighted patient-reported gaps in provider communication regarding treatment-related toxicities in metastatic breast cancer. ....

United States , Emory University School Of Medicine , Janel Meisel , Department Of Gynecology , Department Of Hematology , Quality Of Life , Life Survey , Antonio Breast Cancer Symposium , Medical Oncology , Emory University School , Estrogen Receptor Positive Her2 Negative , Breast Cancer , Treatment Related Adverse Effects , Healthcare Providers , Tolerability Concerns , Shared Decision Making , Esr1 Quality Of Life Survey 3 , Quality Of Life , 2023 San Antonio Breast Cancer Symposium ,